Phillip M. Schneider

CIK: 0001230051

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (66.7%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

SPRY

ARS Pharmaceuticals, Inc.

Director

LBPH

Longboard Pharmaceuticals, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (6 total)

SPRY
ARS Pharmaceuticals, Inc.
Jun 24, 2026
Award(A)
Stock Option (right to buy)
Direct
30K shares-
SPRY
ARS Pharmaceuticals, Inc.
Jun 25, 2025
Award(A)
Stock Option (right to buy)
Direct
30K shares-
LBPH
Longboard Pharmaceuticals, Inc.
Dec 2, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
25.5K shares-
LBPH
Longboard Pharmaceuticals, Inc.
Dec 2, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
12.4K shares-
LBPH
Longboard Pharmaceuticals, Inc.
Dec 2, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
12.5K shares-
LBPH
Longboard Pharmaceuticals, Inc.
Dec 2, 2024
Disposition(D)
Employee Stock Option (right to buy)
Direct
22.5K shares-

		Type	Shares	Price		Ownership
Jun 24, 2026	SPRY ARS Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Jun 25, 2025	SPRY ARS Pharmaceuticals, Inc.	Award(A) Stock Option (right to buy)	30,000	-	-	Direct
Dec 2, 2024	LBPH Longboard Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	25,461	-	-	Direct
Dec 2, 2024	LBPH Longboard Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	12,367	-	-	Direct
Dec 2, 2024	LBPH Longboard Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	12,500	-	-	Direct
Dec 2, 2024	LBPH Longboard Pharmaceuticals, Inc.	Disposition(D) Employee Stock Option (right to buy)	22,500	-	-	Direct

1-6 of 6 transactions

About SCHNEIDER PHILLIP M

SCHNEIDER PHILLIP M (SEC CIK 0001230051) files insider reports with the SEC as Director of ARS Pharmaceuticals, Inc. (SPRY) and Director of Longboard Pharmaceuticals, Inc. (LBPH).

Signal8 holds 3 ownership filings by SCHNEIDER PHILLIP M, all Form 4s, filed between Dec 2, 2024 and Jun 26, 2026. Those filings report 6 transactions, from Dec 2, 2024 to Jun 24, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on SCHNEIDER PHILLIP M's filings is in SAN DIEGO, CA.

Recent filings by SCHNEIDER PHILLIP M

Jun 24, 2026: Grant or award of SPRY derivative securities (Form 4, code A).
Jun 25, 2025: Grant or award of SPRY derivative securities (Form 4, code A).
Dec 2, 2024: Disposition to issuer transactions of LBPH derivative securities (4 lines, Form 4, code D).

Other insiders filing for ARS Pharmaceuticals, Inc. (SPRY)

Casale Donn, President and CEO
Smith Margaret Ekins, Chief Commercial Officer
RA CAPITAL MANAGEMENT, L.P., Director
Dadoo Rajeev, Director
Shah Pratik, Director
Kelly Michael, Director

How to read Form 4 transaction codes